Hclicobactcr pylori and gastroduodenal disease

Kenji Yokota, Yoshikazu Hirai, Keiji Oguma

Research output: Contribution to journalArticle

Abstract

Helicobader pylori is a gram negative spiral bacterium, which is colonized in human gastric mucosa. This organism was first reported in Australia, 1983. Now H. pylori has been recognized to cause chronic active gastritis, and is a major factor in the pathogenesis of duodenal ulcer and gastric ulcer. It was also reported that its infection is a risk factor for both MALT (mucosa associated lymphoid tissue) lymphoma and gastric adenocarcinoma. H. pylori has many virulence factors. Urease is one of the most important colonization and virulence factors studied. Ammonia made by urease protects the organisms from gastric low pH, and is toxigenic to gastric epithelial cells. Vacuolating toxin and CagA proteins are thought to be pathogenic agents especially for causing gastric and duodenal ulcers. Neutrophil reactions against the bacteria, and the abnormal immunological reactions are also considered to cause the damage of gastric epithelial cells, although the detailed pathogenic mechanisms are still not clear. In developing countries, infection by H. pylori is established in childhood, and the organisms can be identified in the mouth and feces, indicating its infection through water. The infected organisms can be eradicated by administration with proton pump inhibitor and one or two antibiotics. This may provide an useful therapeutic means to the patients especially with recurrent ulcération and MALT lymphoma.

Original languageEnglish
Pages (from-to)193-209
Number of pages17
JournalJapanese Journal of Toxicology and Environmental Health
Volume42
Issue number3
Publication statusPublished - 1996

Fingerprint

Pylorus
Stomach
Urease
Virulence Factors
Marginal Zone B-Cell Lymphoma
Bacteria
Stomach Ulcer
Duodenal Ulcer
Tissue
Proton Pump Inhibitors
Infection
Epithelial Cells
Ammonia
Developing countries
Gastritis
Gastric Mucosa
Gram-Negative Bacteria
Feces
Developing Countries
Anti-Bacterial Agents

Keywords

  • Cholesterylglucosides
  • Helicobader pylori
  • Peptic ulcer
  • Urease
  • Vacuolating toxin

ASJC Scopus subject areas

  • Toxicology

Cite this

Hclicobactcr pylori and gastroduodenal disease. / Yokota, Kenji; Hirai, Yoshikazu; Oguma, Keiji.

In: Japanese Journal of Toxicology and Environmental Health, Vol. 42, No. 3, 1996, p. 193-209.

Research output: Contribution to journalArticle

Yokota, Kenji ; Hirai, Yoshikazu ; Oguma, Keiji. / Hclicobactcr pylori and gastroduodenal disease. In: Japanese Journal of Toxicology and Environmental Health. 1996 ; Vol. 42, No. 3. pp. 193-209.
@article{eed707464aca4d3bb454d2d7c6d4bfcb,
title = "Hclicobactcr pylori and gastroduodenal disease",
abstract = "Helicobader pylori is a gram negative spiral bacterium, which is colonized in human gastric mucosa. This organism was first reported in Australia, 1983. Now H. pylori has been recognized to cause chronic active gastritis, and is a major factor in the pathogenesis of duodenal ulcer and gastric ulcer. It was also reported that its infection is a risk factor for both MALT (mucosa associated lymphoid tissue) lymphoma and gastric adenocarcinoma. H. pylori has many virulence factors. Urease is one of the most important colonization and virulence factors studied. Ammonia made by urease protects the organisms from gastric low pH, and is toxigenic to gastric epithelial cells. Vacuolating toxin and CagA proteins are thought to be pathogenic agents especially for causing gastric and duodenal ulcers. Neutrophil reactions against the bacteria, and the abnormal immunological reactions are also considered to cause the damage of gastric epithelial cells, although the detailed pathogenic mechanisms are still not clear. In developing countries, infection by H. pylori is established in childhood, and the organisms can be identified in the mouth and feces, indicating its infection through water. The infected organisms can be eradicated by administration with proton pump inhibitor and one or two antibiotics. This may provide an useful therapeutic means to the patients especially with recurrent ulc{\'e}ration and MALT lymphoma.",
keywords = "Cholesterylglucosides, Helicobader pylori, Peptic ulcer, Urease, Vacuolating toxin",
author = "Kenji Yokota and Yoshikazu Hirai and Keiji Oguma",
year = "1996",
language = "English",
volume = "42",
pages = "193--209",
journal = "Japanese Journal of Toxicology and Environmental Health",
issn = "0013-273X",
publisher = "Pharmaceutical Society of Japan",
number = "3",

}

TY - JOUR

T1 - Hclicobactcr pylori and gastroduodenal disease

AU - Yokota, Kenji

AU - Hirai, Yoshikazu

AU - Oguma, Keiji

PY - 1996

Y1 - 1996

N2 - Helicobader pylori is a gram negative spiral bacterium, which is colonized in human gastric mucosa. This organism was first reported in Australia, 1983. Now H. pylori has been recognized to cause chronic active gastritis, and is a major factor in the pathogenesis of duodenal ulcer and gastric ulcer. It was also reported that its infection is a risk factor for both MALT (mucosa associated lymphoid tissue) lymphoma and gastric adenocarcinoma. H. pylori has many virulence factors. Urease is one of the most important colonization and virulence factors studied. Ammonia made by urease protects the organisms from gastric low pH, and is toxigenic to gastric epithelial cells. Vacuolating toxin and CagA proteins are thought to be pathogenic agents especially for causing gastric and duodenal ulcers. Neutrophil reactions against the bacteria, and the abnormal immunological reactions are also considered to cause the damage of gastric epithelial cells, although the detailed pathogenic mechanisms are still not clear. In developing countries, infection by H. pylori is established in childhood, and the organisms can be identified in the mouth and feces, indicating its infection through water. The infected organisms can be eradicated by administration with proton pump inhibitor and one or two antibiotics. This may provide an useful therapeutic means to the patients especially with recurrent ulcération and MALT lymphoma.

AB - Helicobader pylori is a gram negative spiral bacterium, which is colonized in human gastric mucosa. This organism was first reported in Australia, 1983. Now H. pylori has been recognized to cause chronic active gastritis, and is a major factor in the pathogenesis of duodenal ulcer and gastric ulcer. It was also reported that its infection is a risk factor for both MALT (mucosa associated lymphoid tissue) lymphoma and gastric adenocarcinoma. H. pylori has many virulence factors. Urease is one of the most important colonization and virulence factors studied. Ammonia made by urease protects the organisms from gastric low pH, and is toxigenic to gastric epithelial cells. Vacuolating toxin and CagA proteins are thought to be pathogenic agents especially for causing gastric and duodenal ulcers. Neutrophil reactions against the bacteria, and the abnormal immunological reactions are also considered to cause the damage of gastric epithelial cells, although the detailed pathogenic mechanisms are still not clear. In developing countries, infection by H. pylori is established in childhood, and the organisms can be identified in the mouth and feces, indicating its infection through water. The infected organisms can be eradicated by administration with proton pump inhibitor and one or two antibiotics. This may provide an useful therapeutic means to the patients especially with recurrent ulcération and MALT lymphoma.

KW - Cholesterylglucosides

KW - Helicobader pylori

KW - Peptic ulcer

KW - Urease

KW - Vacuolating toxin

UR - http://www.scopus.com/inward/record.url?scp=0029891854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029891854&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029891854

VL - 42

SP - 193

EP - 209

JO - Japanese Journal of Toxicology and Environmental Health

JF - Japanese Journal of Toxicology and Environmental Health

SN - 0013-273X

IS - 3

ER -